Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review
A systematic review examines neurodevelopmental outcomes in children prenatally exposed to antiepileptic drugs.
Do SSRI Antidepressants Lower Risk of Preeclampsia? Maybe, But It’s Complicated
There is evidence that depression itself can increase risk for preeclampsia. In women with more severe depression, treatment with an SSRI antidepressant may decrease risk.
Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children
The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.
Essential Reads: The Use of Sedative-Hypnotic Drugs During Pregnancy
More study is needed regarding the safety of sedative-hypnotic medications during pregnancy.
NAMI Ask the Expert: A Fireside Chat with Dr. Marlene Freeman and Dr. Ken Duckworth
Dr. Marlene Freeman recently shared her insights on Psychiatric Medications and Considerations for Individuals Across Pregnancy, the Postpartum, and Reproductive Years with the National Alliance on Mental Illness on March 7, 2024.
Neuroimaging Study Sheds Light on the Impact of Maternal Depression and Prenatal Antidepressant Exposure on Fetal Brain Development
At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.
Danish Study Indicates No Increase in Risk of Malformations with Prenatal Exposure to Antipsychotic Medications
This register-based cohort study from Denmark of 503,158 clinically recognized pregnancies observed little or no risk of teratogenesis associated with first trimester exposure to antipsychotic medications.
Neurodevelopmental Outcomes in Children with Exposure to Prescription Stimulants During Pregnancy
Prenatal exposure to prescription stimulants was not associated with an increased risk of neurodevelopmental disorders in exposed children.
Essential Reads: Keeping Up with the Medical Literature in Reproductive Psychiatry
There are many different sources of information, some better than others.
Toward a better framework for postmarketing reproductive safety surveillance of medications
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on zuranolone for postpartum depression with Ob.Gyn News on December 14, 2023.